Selected article for: "antiviral response and limited availability"
Author: Ishay, Yuval; Potruch, Assaf; Schwartz, Asaf; Berg, Marc; Jamil, Khurram; Agus, Samuel; Ilan, Yaron
Title: A digital health platform for assisting the diagnosis and monitoring of COVID-19 progression: An adjuvant approach for augmenting the antiviral response and mitigating the immune-mediated target organ damage
  • Cord-id: 8gzypxqr
  • Document date: 2021_9_22
    • ID: 8gzypxqr
    Snippet: Coronavirus disease 2019 (COVID-19), which is a respiratory illness associated with high mortality, has been classified as a pandemic. The major obstacles for the clinicians to contain the disease are limited information availability, difficulty in disease diagnosis, predicting disease prognosis, and lack of disease monitoring tools. Additionally, the lack of valid therapies has further contributed to the difficulties in containing the pandemic. Recent studies have reported that the dysregulatio
    Document: Coronavirus disease 2019 (COVID-19), which is a respiratory illness associated with high mortality, has been classified as a pandemic. The major obstacles for the clinicians to contain the disease are limited information availability, difficulty in disease diagnosis, predicting disease prognosis, and lack of disease monitoring tools. Additionally, the lack of valid therapies has further contributed to the difficulties in containing the pandemic. Recent studies have reported that the dysregulation of the immune system leads to an ineffective antiviral response and promotes pathological immune response, which manifests as ARDS, myocarditis, and hepatitis. In this study, a novel platform has been described for disseminating information to physicians for the diagnosis and monitoring of patients with COVID-19. An adjuvant approach using compounds that can potentiate antiviral immune response and mitigate COVID-19-induced immune-mediated target organ damage has been presented. A prolonged beneficial effect is achieved by implementing algorithm-based individualized variability measures in the treatment regimen.

    Search related documents:
    Co phrase search for related documents
    • accurate diagnosis and acute respiratory sars syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accurate prediction and activator signal transducer: 1
    • accurate prediction and active cell: 1
    • accurate prediction and acute respiratory infection: 1, 2, 3
    • accurate prediction and acute respiratory sars syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • activation downstream and acute respiratory infection: 1, 2
    • activation downstream and acute respiratory sars syndrome: 1, 2, 3, 4
    • activator signal transducer and acute respiratory infection: 1, 2, 3
    • activator signal transducer and acute respiratory sars syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • active cell and acute respiratory infection: 1, 2
    • active cell and acute respiratory sars syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • active cell apoptosis and acute respiratory sars syndrome: 1